大動脈狭窄症のグローバル市場展望 2023年-2029年：経カテーテル的大動脈弁移植術（TAVI）、外科的大動脈弁置換術（SAVR）

■ 英語タイトル：Aortic Stenosis Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC12255）

■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC12255
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療
■ ページ数：69
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[大動脈狭窄症のグローバル市場展望 2023年-2029年：経カテーテル的大動脈弁移植術（TAVI）、外科的大動脈弁置換術（SAVR）]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の大動脈狭窄症市場規模と予測を収録しています。・世界の大動脈狭窄症市場：売上、2018年-2023年、2024年-2029年
・世界の大動脈狭窄症市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の大動脈狭窄症市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経カテーテル的大動脈弁移植術（TAVI）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

大動脈狭窄症のグローバル主要企業は、Abbott Laboratories、 AstraZeneca Plc.、 Boston Scientific Corporation、 Coroneo、 CryoLife, Inc.、 Edwards Lifesciences Corporation、 JenaValve Technology, Inc.、 LifeNet Health、 LivaNova PLC、 Medtronic Plc、 Meril Life Sciences Pvt. Ltd.、 Thubrikar Aortic Valveなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、大動脈狭窄症のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の大動脈狭窄症市場：タイプ別、2018年-2023年、2024年-2029年
世界の大動脈狭窄症市場：タイプ別市場シェア、2022年
・経カテーテル的大動脈弁移植術（TAVI）、外科的大動脈弁置換術（SAVR）

世界の大動脈狭窄症市場：用途別、2018年-2023年、2024年-2029年
世界の大動脈狭窄症市場：用途別市場シェア、2022年
・先天性大動脈狭窄症、後天性大動脈狭窄症

世界の大動脈狭窄症市場：地域・国別、2018年-2023年、2024年-2029年
世界の大動脈狭窄症市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における大動脈狭窄症のグローバル売上、2018年-2023年
・主要企業における大動脈狭窄症のグローバル売上シェア、2022年
・主要企業における大動脈狭窄症のグローバル販売量、2018年-2023年
・主要企業における大動脈狭窄症のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Abbott Laboratories、 AstraZeneca Plc.、 Boston Scientific Corporation、 Coroneo、 CryoLife, Inc.、 Edwards Lifesciences Corporation、 JenaValve Technology, Inc.、 LifeNet Health、 LivaNova PLC、 Medtronic Plc、 Meril Life Sciences Pvt. Ltd.、 Thubrikar Aortic Valve

*************************************************************

・調査・分析レポートの概要
大動脈狭窄症市場の定義
市場セグメント
世界の大動脈狭窄症市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の大動脈狭窄症市場規模
世界の大動脈狭窄症市場規模：2022年 VS 2029年
世界の大動脈狭窄症市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの大動脈狭窄症の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の大動脈狭窄症製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経カテーテル的大動脈弁移植術（TAVI）、外科的大動脈弁置換術（SAVR）
大動脈狭窄症のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：先天性大動脈狭窄症、後天性大動脈狭窄症
大動脈狭窄症の用途別グローバル売上・予測

・地域別市場分析
地域別大動脈狭窄症市場規模 2022年と2029年
地域別大動脈狭窄症売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Abbott Laboratories、 AstraZeneca Plc.、 Boston Scientific Corporation、 Coroneo、 CryoLife, Inc.、 Edwards Lifesciences Corporation、 JenaValve Technology, Inc.、 LifeNet Health、 LivaNova PLC、 Medtronic Plc、 Meril Life Sciences Pvt. Ltd.、 Thubrikar Aortic Valve
...

This research report provides a comprehensive analysis of the Aortic Stenosis market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Aortic Stenosis market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Aortic Stenosis, challenges faced by the industry, and potential opportunities for market players.
The global Aortic Stenosis market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Aortic Stenosis market presents opportunities for various stakeholders, including Congenital Aortic Stenosis, Acquired Aortic Stenosis. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Aortic Stenosis market. Additionally, the growing consumer demand present avenues for market expansion.
The global Aortic Stenosis market was valued at US$ 5091.3 million in 2022 and is projected to reach US$ 10300 million by 2029, at a CAGR of 10.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Aortic Stenosis market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Aortic Stenosis market.
Market Overview: The report provides a comprehensive overview of the Aortic Stenosis market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Transcatheter Aortic Valve Implantation (TAVI), Surgical Aortic Valve Replacement (SAVR)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Aortic Stenosis market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Aortic Stenosis market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Aortic Stenosis market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Aortic Stenosis market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Aortic Stenosis market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Aortic Stenosis market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Aortic Stenosis, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Aortic Stenosis market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Aortic Stenosis market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Transcatheter Aortic Valve Implantation (TAVI)
Surgical Aortic Valve Replacement (SAVR)
Market segment by Application
Congenital Aortic Stenosis
Acquired Aortic Stenosis
Global Aortic Stenosis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Abbott Laboratories
AstraZeneca Plc.
Boston Scientific Corporation
Coroneo
CryoLife, Inc.
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
LifeNet Health
LivaNova PLC
Medtronic Plc
Meril Life Sciences Pvt. Ltd.
Thubrikar Aortic Valve
Outline of Major Chapters:
Chapter 1: Introduces the definition of Aortic Stenosis, market overview.
Chapter 2: Global Aortic Stenosis market size in revenue.
Chapter 3: Detailed analysis of Aortic Stenosis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Aortic Stenosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Aortic Stenosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Aortic Stenosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Aortic Stenosis Overall Market Size
2.1 Global Aortic Stenosis Market Size: 2022 VS 2029
2.2 Global Aortic Stenosis Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Aortic Stenosis Players in Global Market
3.2 Top Global Aortic Stenosis Companies Ranked by Revenue
3.3 Global Aortic Stenosis Revenue by Companies
3.4 Top 3 and Top 5 Aortic Stenosis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Aortic Stenosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Aortic Stenosis Players in Global Market
3.6.1 List of Global Tier 1 Aortic Stenosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Aortic Stenosis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Aortic Stenosis Market Size Markets, 2022 & 2029
4.1.2 Transcatheter Aortic Valve Implantation (TAVI)
4.1.3 Surgical Aortic Valve Replacement (SAVR)
4.2 By Type – Global Aortic Stenosis Revenue & Forecasts
4.2.1 By Type – Global Aortic Stenosis Revenue, 2018-2023
4.2.2 By Type – Global Aortic Stenosis Revenue, 2024-2029
4.2.3 By Type – Global Aortic Stenosis Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Aortic Stenosis Market Size, 2022 & 2029
5.1.2 Congenital Aortic Stenosis
5.1.3 Acquired Aortic Stenosis
5.2 By Application – Global Aortic Stenosis Revenue & Forecasts
5.2.1 By Application – Global Aortic Stenosis Revenue, 2018-2023
5.2.2 By Application – Global Aortic Stenosis Revenue, 2024-2029
5.2.3 By Application – Global Aortic Stenosis Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Aortic Stenosis Market Size, 2022 & 2029
6.2 By Region – Global Aortic Stenosis Revenue & Forecasts
6.2.1 By Region – Global Aortic Stenosis Revenue, 2018-2023
6.2.2 By Region – Global Aortic Stenosis Revenue, 2024-2029
6.2.3 By Region – Global Aortic Stenosis Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Aortic Stenosis Revenue, 2018-2029
6.3.2 US Aortic Stenosis Market Size, 2018-2029
6.3.3 Canada Aortic Stenosis Market Size, 2018-2029
6.3.4 Mexico Aortic Stenosis Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Aortic Stenosis Revenue, 2018-2029
6.4.2 Germany Aortic Stenosis Market Size, 2018-2029
6.4.3 France Aortic Stenosis Market Size, 2018-2029
6.4.4 U.K. Aortic Stenosis Market Size, 2018-2029
6.4.5 Italy Aortic Stenosis Market Size, 2018-2029
6.4.6 Russia Aortic Stenosis Market Size, 2018-2029
6.4.7 Nordic Countries Aortic Stenosis Market Size, 2018-2029
6.4.8 Benelux Aortic Stenosis Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Aortic Stenosis Revenue, 2018-2029
6.5.2 China Aortic Stenosis Market Size, 2018-2029
6.5.3 Japan Aortic Stenosis Market Size, 2018-2029
6.5.4 South Korea Aortic Stenosis Market Size, 2018-2029
6.5.5 Southeast Asia Aortic Stenosis Market Size, 2018-2029
6.5.6 India Aortic Stenosis Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Aortic Stenosis Revenue, 2018-2029
6.6.2 Brazil Aortic Stenosis Market Size, 2018-2029
6.6.3 Argentina Aortic Stenosis Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Aortic Stenosis Revenue, 2018-2029
6.7.2 Turkey Aortic Stenosis Market Size, 2018-2029
6.7.3 Israel Aortic Stenosis Market Size, 2018-2029
6.7.4 Saudi Arabia Aortic Stenosis Market Size, 2018-2029
6.7.5 UAE Aortic Stenosis Market Size, 2018-2029
7 Aortic Stenosis Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Aortic Stenosis Major Product Offerings
7.1.4 Abbott Laboratories Aortic Stenosis Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 AstraZeneca Plc.
7.2.1 AstraZeneca Plc. Company Summary
7.2.2 AstraZeneca Plc. Business Overview
7.2.3 AstraZeneca Plc. Aortic Stenosis Major Product Offerings
7.2.4 AstraZeneca Plc. Aortic Stenosis Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Plc. Key News & Latest Developments
7.3 Boston Scientific Corporation
7.3.1 Boston Scientific Corporation Company Summary
7.3.2 Boston Scientific Corporation Business Overview
7.3.3 Boston Scientific Corporation Aortic Stenosis Major Product Offerings
7.3.4 Boston Scientific Corporation Aortic Stenosis Revenue in Global Market (2018-2023)
7.3.5 Boston Scientific Corporation Key News & Latest Developments
7.4 Coroneo
7.4.1 Coroneo Company Summary
7.4.2 Coroneo Business Overview
7.4.3 Coroneo Aortic Stenosis Major Product Offerings
7.4.4 Coroneo Aortic Stenosis Revenue in Global Market (2018-2023)
7.4.5 Coroneo Key News & Latest Developments
7.5 CryoLife, Inc.
7.5.1 CryoLife, Inc. Company Summary
7.5.2 CryoLife, Inc. Business Overview
7.5.3 CryoLife, Inc. Aortic Stenosis Major Product Offerings
7.5.4 CryoLife, Inc. Aortic Stenosis Revenue in Global Market (2018-2023)
7.5.5 CryoLife, Inc. Key News & Latest Developments
7.6 Edwards Lifesciences Corporation
7.6.1 Edwards Lifesciences Corporation Company Summary
7.6.2 Edwards Lifesciences Corporation Business Overview
7.6.3 Edwards Lifesciences Corporation Aortic Stenosis Major Product Offerings
7.6.4 Edwards Lifesciences Corporation Aortic Stenosis Revenue in Global Market (2018-2023)
7.6.5 Edwards Lifesciences Corporation Key News & Latest Developments
7.7 JenaValve Technology, Inc.
7.7.1 JenaValve Technology, Inc. Company Summary
7.7.2 JenaValve Technology, Inc. Business Overview
7.7.3 JenaValve Technology, Inc. Aortic Stenosis Major Product Offerings
7.7.4 JenaValve Technology, Inc. Aortic Stenosis Revenue in Global Market (2018-2023)
7.7.5 JenaValve Technology, Inc. Key News & Latest Developments
7.8 LifeNet Health
7.8.1 LifeNet Health Company Summary
7.8.2 LifeNet Health Business Overview
7.8.3 LifeNet Health Aortic Stenosis Major Product Offerings
7.8.4 LifeNet Health Aortic Stenosis Revenue in Global Market (2018-2023)
7.8.5 LifeNet Health Key News & Latest Developments
7.9 LivaNova PLC
7.9.1 LivaNova PLC Company Summary
7.9.2 LivaNova PLC Business Overview
7.9.3 LivaNova PLC Aortic Stenosis Major Product Offerings
7.9.4 LivaNova PLC Aortic Stenosis Revenue in Global Market (2018-2023)
7.9.5 LivaNova PLC Key News & Latest Developments
7.10 Medtronic Plc
7.10.1 Medtronic Plc Company Summary
7.10.2 Medtronic Plc Business Overview
7.10.3 Medtronic Plc Aortic Stenosis Major Product Offerings
7.10.4 Medtronic Plc Aortic Stenosis Revenue in Global Market (2018-2023)
7.10.5 Medtronic Plc Key News & Latest Developments
7.11 Meril Life Sciences Pvt. Ltd.
7.11.1 Meril Life Sciences Pvt. Ltd. Company Summary
7.11.2 Meril Life Sciences Pvt. Ltd. Business Overview
7.11.3 Meril Life Sciences Pvt. Ltd. Aortic Stenosis Major Product Offerings
7.11.4 Meril Life Sciences Pvt. Ltd. Aortic Stenosis Revenue in Global Market (2018-2023)
7.11.5 Meril Life Sciences Pvt. Ltd. Key News & Latest Developments
7.12 Thubrikar Aortic Valve
7.12.1 Thubrikar Aortic Valve Company Summary
7.12.2 Thubrikar Aortic Valve Business Overview
7.12.3 Thubrikar Aortic Valve Aortic Stenosis Major Product Offerings
7.12.4 Thubrikar Aortic Valve Aortic Stenosis Revenue in Global Market (2018-2023)
7.12.5 Thubrikar Aortic Valve Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Aortic Stenosis Market Opportunities & Trends in Global Market
Table 2. Aortic Stenosis Market Drivers in Global Market
Table 3. Aortic Stenosis Market Restraints in Global Market
Table 4. Key Players of Aortic Stenosis in Global Market
Table 5. Top Aortic Stenosis Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Aortic Stenosis Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Aortic Stenosis Revenue Share by Companies, 2018-2023
Table 8. Global Companies Aortic Stenosis Product Type
Table 9. List of Global Tier 1 Aortic Stenosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Aortic Stenosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Aortic Stenosis Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Aortic Stenosis Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Aortic Stenosis Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Aortic Stenosis Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Aortic Stenosis Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Aortic Stenosis Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Aortic Stenosis Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Aortic Stenosis Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Aortic Stenosis Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Aortic Stenosis Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Aortic Stenosis Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Aortic Stenosis Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Aortic Stenosis Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Aortic Stenosis Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Aortic Stenosis Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Aortic Stenosis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Aortic Stenosis Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Aortic Stenosis Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Aortic Stenosis Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Aortic Stenosis Product Offerings
Table 32. Abbott Laboratories Aortic Stenosis Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. AstraZeneca Plc. Company Summary
Table 35. AstraZeneca Plc. Aortic Stenosis Product Offerings
Table 36. AstraZeneca Plc. Aortic Stenosis Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Plc. Key News & Latest Developments
Table 38. Boston Scientific Corporation Company Summary
Table 39. Boston Scientific Corporation Aortic Stenosis Product Offerings
Table 40. Boston Scientific Corporation Aortic Stenosis Revenue (US$, Mn) & (2018-2023)
Table 41. Boston Scientific Corporation Key News & Latest Developments
Table 42. Coroneo Company Summary
Table 43. Coroneo Aortic Stenosis Product Offerings
Table 44. Coroneo Aortic Stenosis Revenue (US$, Mn) & (2018-2023)
Table 45. Coroneo Key News & Latest Developments
Table 46. CryoLife, Inc. Company Summary
Table 47. CryoLife, Inc. Aortic Stenosis Product Offerings
Table 48. CryoLife, Inc. Aortic Stenosis Revenue (US$, Mn) & (2018-2023)
Table 49. CryoLife, Inc. Key News & Latest Developments
Table 50. Edwards Lifesciences Corporation Company Summary
Table 51. Edwards Lifesciences Corporation Aortic Stenosis Product Offerings
Table 52. Edwards Lifesciences Corporation Aortic Stenosis Revenue (US$, Mn) & (2018-2023)
Table 53. Edwards Lifesciences Corporation Key News & Latest Developments
Table 54. JenaValve Technology, Inc. Company Summary
Table 55. JenaValve Technology, Inc. Aortic Stenosis Product Offerings
Table 56. JenaValve Technology, Inc. Aortic Stenosis Revenue (US$, Mn) & (2018-2023)
Table 57. JenaValve Technology, Inc. Key News & Latest Developments
Table 58. LifeNet Health Company Summary
Table 59. LifeNet Health Aortic Stenosis Product Offerings
Table 60. LifeNet Health Aortic Stenosis Revenue (US$, Mn) & (2018-2023)
Table 61. LifeNet Health Key News & Latest Developments
Table 62. LivaNova PLC Company Summary
Table 63. LivaNova PLC Aortic Stenosis Product Offerings
Table 64. LivaNova PLC Aortic Stenosis Revenue (US$, Mn) & (2018-2023)
Table 65. LivaNova PLC Key News & Latest Developments
Table 66. Medtronic Plc Company Summary
Table 67. Medtronic Plc Aortic Stenosis Product Offerings
Table 68. Medtronic Plc Aortic Stenosis Revenue (US$, Mn) & (2018-2023)
Table 69. Medtronic Plc Key News & Latest Developments
Table 70. Meril Life Sciences Pvt. Ltd. Company Summary
Table 71. Meril Life Sciences Pvt. Ltd. Aortic Stenosis Product Offerings
Table 72. Meril Life Sciences Pvt. Ltd. Aortic Stenosis Revenue (US$, Mn) & (2018-2023)
Table 73. Meril Life Sciences Pvt. Ltd. Key News & Latest Developments
Table 74. Thubrikar Aortic Valve Company Summary
Table 75. Thubrikar Aortic Valve Aortic Stenosis Product Offerings
Table 76. Thubrikar Aortic Valve Aortic Stenosis Revenue (US$, Mn) & (2018-2023)
Table 77. Thubrikar Aortic Valve Key News & Latest Developments
List of Figures
Figure 1. Aortic Stenosis Segment by Type in 2022
Figure 2. Aortic Stenosis Segment by Application in 2022
Figure 3. Global Aortic Stenosis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Aortic Stenosis Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Aortic Stenosis Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Aortic Stenosis Revenue in 2022
Figure 8. By Type - Global Aortic Stenosis Revenue Market Share, 2018-2029
Figure 9. By Application - Global Aortic Stenosis Revenue Market Share, 2018-2029
Figure 10. By Type - Global Aortic Stenosis Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Aortic Stenosis Revenue Market Share, 2018-2029
Figure 12. By Application - Global Aortic Stenosis Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Aortic Stenosis Revenue Market Share, 2018-2029
Figure 14. By Region - Global Aortic Stenosis Revenue Market Share, 2018-2029
Figure 15. By Country - North America Aortic Stenosis Revenue Market Share, 2018-2029
Figure 16. US Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Aortic Stenosis Revenue Market Share, 2018-2029
Figure 20. Germany Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 21. France Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Aortic Stenosis Revenue Market Share, 2018-2029
Figure 28. China Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 32. India Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Aortic Stenosis Revenue Market Share, 2018-2029
Figure 34. Brazil Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Aortic Stenosis Revenue Market Share, 2018-2029
Figure 37. Turkey Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Aortic Stenosis Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Laboratories Aortic Stenosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Plc. Aortic Stenosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boston Scientific Corporation Aortic Stenosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Coroneo Aortic Stenosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. CryoLife, Inc. Aortic Stenosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Edwards Lifesciences Corporation Aortic Stenosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. JenaValve Technology, Inc. Aortic Stenosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. LifeNet Health Aortic Stenosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. LivaNova PLC Aortic Stenosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Medtronic Plc Aortic Stenosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Meril Life Sciences Pvt. Ltd. Aortic Stenosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Thubrikar Aortic Valve Aortic Stenosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

大動脈狭窄症のグローバル市場展望 2023年-2029年：経カテーテル的大動脈弁移植術（TAVI）、外科的大動脈弁置換術（SAVR）

グローバル市場調査会社